| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/16/2009 | WO2009047587A1 Magnetic, paramagnetic and/or superparamagnetic nanoparticles |
| 04/16/2009 | WO2009047319A1 Contrast agents |
| 04/16/2009 | WO2009047318A1 Contrast agents |
| 04/16/2009 | WO2009047317A1 Contrast agents |
| 04/16/2009 | WO2009047316A1 Contrast agents |
| 04/16/2009 | WO2009047315A1 Contrast agents |
| 04/16/2009 | WO2009047301A1 Method for the recombinant production of magnetic nanoparticles |
| 04/16/2009 | WO2008139206A3 Optical imaging agents |
| 04/16/2009 | WO2008095603A3 Color-marked oligosaccharides or polysaccharides |
| 04/16/2009 | WO2007113819A3 Methods and compositions for preventing and treating streptococcus pneumoniae infection |
| 04/16/2009 | WO2007030124A3 Treatment screening methods |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090098059 Contrast agents |
| 04/16/2009 | US20090098058 Method of injecting liquid agents at acupuncture points to arrive internal organs and method of visualizing arrival of liquid agents |
| 04/16/2009 | US20090098057 Silica-cored carrier particle |
| 04/16/2009 | US20090098054 Methods and compositions relating to promoter regulation by muc1 and klf proteins |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090098052 Transgenic mice |
| 04/16/2009 | US20090098051 Bacillus thuringiensis toxin |
| 04/16/2009 | US20090098050 Calcium binding peptides |
| 04/16/2009 | US20090098049 Targeting transducible molecules to specific cell types |
| 04/16/2009 | US20090098047 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 04/16/2009 | US20090098046 Combination Cancer Therapy with Anti-PSMA Antibodies |
| 04/16/2009 | CA2702190A1 Injectable radio-opaque compositions for tissue augmentation |
| 04/15/2009 | EP2047250A2 Photo-acoustic detection device and method |
| 04/15/2009 | EP2046895A2 Asymmetric fluoro-substituted polymethine dyes |
| 04/15/2009 | EP2046395A1 Microbubbles as drug delivery device |
| 04/15/2009 | EP2046392A2 Radiodense conjugate |
| 04/15/2009 | EP2046288A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 04/15/2009 | CN101410141A Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect |
| 04/15/2009 | CN101410140A Engineered antibody-stress protein fusions |
| 04/15/2009 | CN101407815A Preparing method of glycine-N-methyltransferase (GNMT) knockout mouse model and use thereof |
| 04/15/2009 | CN101407543A Labelled glutamine and lysine analogues |
| 04/15/2009 | CN101406706A Microcapsular ultrasound contrast agent based on surfactant and preparation method thereof |
| 04/15/2009 | CN101406705A Gastric mucosa calibration reagents and preparation method |
| 04/14/2009 | US7519408 Integrated receiver for continuous analyte sensor |
| 04/14/2009 | US7517903 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity |
| 04/14/2009 | US7517518 Using expression of tumor marker protein (CA 125) as indicator of bacterial infection |
| 04/14/2009 | CA2427732C Methods and devices for dissolving hyperpolarised solid material for nmr analyses |
| 04/14/2009 | CA2318576C Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 04/09/2009 | WO2009046457A2 Imaging of genetic material with magnetic resonance |
| 04/09/2009 | WO2009046281A2 Injectable particles |
| 04/09/2009 | WO2009045535A2 Fluorine-18 derivative of dasatinib and uses thereof |
| 04/09/2009 | WO2009045406A1 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/09/2009 | WO2009043962A1 Intracellular device which can be used as a biological activity sensor element or actuator |
| 04/09/2009 | WO2009022279A3 Quinoline as contrast agent in laser induced fluorescence (lif) for lesions |
| 04/09/2009 | WO2008147869A3 Markers and methods for assessing and treating crohn's disease and related disorders |
| 04/09/2009 | WO2008060399A3 X-ray contrast agents comprising a metal chelate and a polyhalogenated phenol, thiophenol, resorcinol, thioresorcinol or dithioresorcinol |
| 04/09/2009 | WO2008028031A3 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 43 gene panel |
| 04/09/2009 | WO2007105214A3 Cascade analysis for intestinal contraction detection |
| 04/09/2009 | WO2006122237A3 Imaging of neural and organ injury or damage |
| 04/09/2009 | WO2006104510A3 Water-soluble compound |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005059099A3 Human ipla2t |
| 04/09/2009 | WO2005055942A3 Modulation of brain pathways and function |
| 04/09/2009 | WO2005041865A3 Compounds and method for treating cancer |
| 04/09/2009 | WO2005025513A3 Guanidinium derivatives for improved cellular transport |
| 04/09/2009 | US20090093738 Device and method for monitoring a treatment area |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090093014 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 04/09/2009 | US20090092555 Octameric Protein For Use In Bionanotechnology Applications |
| 04/09/2009 | US20090092554 Encapsulated contrast agents |
| 04/09/2009 | US20090092552 Light stablized in vivo stain composition and method of manufacture |
| 04/09/2009 | US20090092551 Increasing lifespan by modulation of pha-4 |
| 04/09/2009 | US20090092550 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | US20090091325 Method of determining damage to skin |
| 04/09/2009 | DE20321722U1 Herstellung eines Färbemittels zur Anfärbung von Zellen im menschlichen oder tierischen Körper Preparing a colorant for staining cells in the human or animal body |
| 04/09/2009 | DE20321721U1 Herstellung eines Färbemittels zur Anfärbung von Zellen im menschlichen oder tierischen Körper Preparing a colorant for staining cells in the human or animal body |
| 04/09/2009 | DE102007039899B3 Sensor zum Ermöglichen des Nachweises einer Substanz im Körper eines Lebewesens Sensor to allow the detection of a substance in the body of a living |
| 04/08/2009 | EP2044961A2 Phospholipid analogues for the treatment of cancers |
| 04/08/2009 | EP2044960A2 Phospholipid analogues for the treatment and diagnosis of cancers |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2043697A2 Delivery of contrasting agents for magnetic resonance imaging |
| 04/08/2009 | EP2043696A2 Methods and compositions for targeting gc1qr/p32 |
| 04/08/2009 | EP2043695A2 Models for vaccine assessment |
| 04/08/2009 | EP2043694A2 A probe for cellular oxygen |
| 04/08/2009 | EP2043689A2 Drug delivery with stimulus responsive biopolymers |
| 04/08/2009 | EP0961612B1 Protein stabilized pharmacologically active agents and their use |
| 04/08/2009 | CN101401943A Synthesis of oligomerized fragrant amide-containing paramagnetic metallo-chelates contrast medium |
| 04/08/2009 | CN101401728A Construction method for digitized virtual hand and longitudinal shaped severed finger anatomic structure model |
| 04/08/2009 | CN100475707C Method for preparing magnetic Nano composite granules coated by cationic polyelectrolyte |
| 04/07/2009 | US7515953 Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
| 04/07/2009 | US7514592 transgenic rodents genetically engineered to knock out gene expression of active scavenger receptor class BI (SR-BI) and having apolipoprotein E activity or expression decreased to 2-5% of normal levels; models of cardiovascular disoders induced by feeding a lipid enriched diet |
| 04/07/2009 | CA2457564C Particle immobilized coatings and uses thereof |
| 04/07/2009 | CA2451852C Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy |
| 04/02/2009 | WO2009042168A2 Magnetic resonance contrast using fictitious field relaxation |
| 04/02/2009 | WO2009040843A2 Preparation of micro or nano systems detectable in biological environments based on inorganic oxides with controlled porosity for carrying biologically active or activable substances |
| 04/02/2009 | WO2009040811A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/02/2009 | WO2009040411A1 Photodynamic therapy and diagnosis using a chlorin e4 zinc complex |
| 04/02/2009 | WO2008150490A3 Uses and compositions for treatment of psoriasis and crohn's disease |
| 04/02/2009 | WO2008075081A3 Composition and method for detection of demineralisation |
| 04/02/2009 | WO2007046811A3 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 04/02/2009 | WO2006023658A3 Method of pre-selecting patients for anti-vegf, anti-hif-1 or anti-thioredoxin therapy |
| 04/02/2009 | WO2005051170A3 Integrated receiver for continuous analyte sensor |
| 04/02/2009 | US20090088578 Nuclear magnetic resonance imaging of selective small molecule drugs as contrast agents |
| 04/02/2009 | US20090087384 Medicine and method for treatment of prostate cancer |